Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/22
End: 05/31/23
Due: 05/31/24
Phase: N/A
Priority: Normal
Start: 12/31/21
End: 04/30/23
Due: 04/30/24
Phase: N/A
Priority: Normal
Start: 12/31/22
End: 02/29/24
Due: 02/28/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001 | NCT05137444 | Yantai Patronus Biotech Co., Ltd. | user2@example.com | None | 2022-01-31 | 2023-05-31 | 2024-05-31 | - | - | 2025-07-14 |
| A Phase Ⅰ Trial to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine LYB001 | NCT05125926 | Yantai Patronus Biotech Co., Ltd. | user2@example.com | None | 2021-12-31 | 2023-04-30 | 2024-04-30 | - | - | 2025-07-14 |
| The Phase Ⅱ/Ⅲ Trial of LYB001 | NCT05602558 | Yantai Patronus Biotech Co., Ltd. | user2@example.com | None | 2022-12-31 | 2024-02-29 | 2025-02-28 | - | - | 2025-07-14 |